申请人:Urleb Uros
公开号:US20080004256A1
公开(公告)日:2008-01-03
The compounds of the formula I
and pharmaceutically acceptable salts thereof and a process for preparing the same and pharmaceutical compositions containing the same are described wherein the substituents have the meaning as specified in the description. The compounds are used as thrombin inhibitors.
本文描述了化学式I的化合物及其药用可接受的盐,并提供了制备这些化合物的方法和含有这些化合物的药物组合物。其中,取代基的含义如说明书所述。这些化合物可用作凝血酶抑制剂。